Hypertrophic Cardiomyopathy | 2024 | Canadian Cardiovascular Society Clinical Practice Update on Contemporary Management of the Patient with Hypertrophic Cardiomyopathy | Clinical Practice Update | View |
MINOCA | 2024 | Canadian Cardiovascular Society/Canadian Women’s Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA) | Clinical Practice Update | View |
Post-Cardiac Arrest | 2024 | Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care | Clinical Practice Update | View |
Fitness to Drive | 2024 | Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive | Guideline | View |
Antiplatelet Therapy | 2024 | Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy | Guideline | View |
Team Model and Care Pathways for Aortic Disease | 2023 | The Aortic Team Model and Collaborative Decision Pathways for the Management of Complex Aortic Disease: Clinical Practice Update From the Canadian Cardiovascular Society/Canadian Society of Cardiac Surgeons/Canadian Society for Vascular Surgery/Canadian Association for Interventional Radiology | Clinical Practice Update | View |
Prolonged QT Interval | 2023 | 2023 Canadian Cardiovascular Society Clinical Practice Update on Management of the Patient With a Prolonged QT Interval | Clinical Practice Update | View |
HF Phenotypes | 2023 | Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes | Clinical Practice Update | View |
Neuroprognostication | 2023 | Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position Statement | Position Statement | View |
Pediatric Dyslipidemia | 2022 | The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update | Clinical Practice Update | View |
Cardiorenal | 2022 | 2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults | Guideline | View |
Peripheral Arterial Disease | 2022 | Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease | Guideline | View |
Cardiovascular/Heart Disease | 2022 | Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults with Congenital Heart Disease | Guideline | View |
Cardiovascular/Heart Disease | 2021 | CCS: Clinical Practice Update on Cardiovascular Management of the Pregnant Patient | Clinical Practice Update | View |
Imaging/Device Therapy | 2021 | 2021 Update on the Safety of Magnetic Resonance Imaging: a Joint Position Statement from the CCS/CanSCMR/CHRS | Position Statement | View |
Heart Failure | 2021 | CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for HFrEF | Guideline | View |
Dyslipidemia | 2021 | 2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult | Guideline | View |
Atrial Fibrillation | 2020 | 2020 CCS/CHRS Comprehensive Guidelines for the Management of Atrial Fibrillation | Guideline | View |
Arrhythmia | 2020 | 2020 CCS/CHRS Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients with Structural Heart Disease | Position Statement | View |
Cardiovascular/Heart Disease | 2020 | CCS Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance | Position Statement | View |
Heart Failure | 2020 | CCS/CHFS Joint Position Statement on the Evaluation and Management of Patients with Cardiac Amyloidosis | Position Statement | View |
Heart Failure | 2020 | CCS Heart Failure Guidelines Update: Focus on FMR, SGLT2 Inhibitors, ARNI in HFpEF, and Amyloidosis | Guideline | View |
Prevention / Risk | 2020 | CCS/CTS Position Statement on Pulmonary Hypertension | Position Statement | View |
Syncope | 2020 | CCS Clinical Practice Update on the Assessment and Management of Syncope | Clinical Practice Update | View |
Transplantation | 2020 | CCS/CCTN Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care | Position Statement | View |
CAD/ACS | 2019 | 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion | Guideline | View |
Cardiovascular/Heart Disease | 2019 | 2019 CCS Position Statement for Transcatheter Aortic Valve Implantation | Position Statement | View |
Antiplatelet Therapy | 2018 | 2018 CCS/CAIC Focused Update of the Guidelines for the use of Antiplatelet Therapy | Guideline | View |
Atrial Fibrillation | 2018 | 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Supplementary Material: Management of Atrial Fibrillation: Complete CCS Guidelines Listing | Guideline | View |
Dyslipidemia | 2018 | Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018 | Position Statement | View |
Prevention / Risk | 2018 | Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes | Position Statement | View |
Heart Failure | 2017 | 2017 Comprehensive Update of the CCS Guidelines for the Management of Heart Failure | Guideline | |
Cardiac Arrest | 2017 | Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on the Optimal Care of the Post Arrest Patient | Position Statement | |
Atrial Fibrillation | 2016 | Supplementary Material: Complete Guidelines Listing – 2010 to 2016 | Guideline | |
Atrial Fibrillation | 2016 | The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the CCS Guidelines | Commentary | |
Atrial Fibrillation | 2016 | 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Corrigendum: Published online November 29, 2016 | Guideline | |
Cardiovascular/Heart Disease | 2016 | Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy | Guideline | |
Device Therapy | 2016 | CCS/CHRS 2016 Implantable Cardioverter-Defibrillator (ICD) Guidelines | Guideline | |
Dyslipidemia | 2016 | 2016 Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Application of GRADE and Evidence Review | Guideline | |
Heart Disease | 2016 | CCS/CPCA Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease | Position Statement | |
Perioperative | 2016 | CCS guidelines on perioperative cardiac risk assessment and management for patients undergoing noncardiac surgery | Guideline | |
Syncope | 2016 | CCS and CPCA Position Statement on the Approach to Syncope in the Pediatric Patient | Position Statement | |
Thoracic Aortic Disease | 2016 | CCS/CSCS/CSVS Position Statement on Open and Endovascular Surgery for Thoracic Aortic Disease | Position Statement | |
Atrial Fibrillation | 2015 | The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the CCS Guidelines | Commentary | |
Heart Failure | 2015 | The CCS Heart Failure Companion: Bridging Guidelines to your Practice Supplementary Material: Survey for Practical HF Guidelines Implementations by Canadian Experts | Commentary | |
Atrial Fibrillation | 2014 | Supplementary Material: Complete Guidelines Listing – 2010 to 2014 | Guideline | |
Atrial Fibrillation | 2014 | Atrial Fibrillation Guidelines 2014 Focused Update: Management of Atrial Fibrillation Errata: Published online June 15 2015, Published in issue: December 2014 | Guideline | |
CAD/ACS | 2014 | Revascularization—Multivessel Coronary Artery Disease – A CCS/CAIC/CSCS Joint Position Statement | Position Statement | |
Cardiovascular/Heart Disease | 2014 | Stable Ischemic Heart Disease Guidelines for Diagnosis and Management | Guideline | |
Dyslipidemia | 2014 | Familial Hypercholesterolemia: CCS Position Statement | Position Statement | |
Dyslipidemia | 2014 | Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel | Commentary | |
Heart Failure | 2014 | Heart Failure Guidelines 2014 Update: Focus on Anemia, Biomarkers, and Recent Therapeutic Trial Implications Erratum: Published online August 27 2015 | Guideline | |
Thoracic Aortic Disease | 2014 | Management of Thoracic Aortic Disease | Position Statement | |
Device Therapy | 2013 | Cardiac Resynchronization Therapy Guidelines: Implementation | Guideline | |
Device Therapy | 2013 | Use of Remote Monitoring for Cardiovascular Implantable Electronic Device Follow-up – A Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement | Position Statement | |
Heart Failure | 2013 | Heart Failure Guidelines 2013 Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization | Guideline | |
Imaging / Echo | 2013 | Radiation Exposure From Cardiac Imaging and Interventional Procedures | Position Statement | |
Angina | 2012 | Management of Patients With Refractory Angina – A Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines | Guideline | |
Antiplatelet Therapy | 2012 | Antiplatelet Therapy Guidelines 2012 Update: The Use of Antiplatelet Therapy | Guideline | |
Assessment to Drive/Fly | 2012 | Fitness to Drive and Fly Guidelines 2012 Update: Fitness Following Left Ventricular Assist Device Implantation | Position Statement | |
Atrial Fibrillation | 2012 | Atrial Fibrillation Guidelines 2012 Update: Recommendations for Stroke Prevention and Rate/Rhythm Control | Guideline | |
Cardiovascular/Heart Disease | 2012 | Transcatheter Aortic Valve Implantation | Position Statement | |
Device Therapy | 2012 | Cardiac Resynchronization Therapy Guidelines: Evidence and Patient Selection | Guideline | |
Device Therapy | 2012 | Perioperative Management of Patients With Implanted Pacemakers, Defibrillators, and Neurostimulating Devices – Canadian Cardiovascular Society/Canadian Anesthesiologists’ Society/Canadian Heart Rhythm Society Joint Position Statement | Position Statement | |
Dyslipidemia | 2012 | Dyslipidemia Guidelines 2012 Update: Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult | Guideline | |
Heart Failure | 2012 | Heart Failure Guidelines 2012 Update: Focus on Acute and Chronic Heart Failure | Guideline | |
Paediatric Cardiology | 2012 | Presentation, Diagnosis, and Medical Management of Heart Failure in Children | Guideline | |
Arrhythmia | 2011 | Genetic Testing in the Clinical Evaluation of Inherited Cardiac Arrhythmias Associated with Sudden Cardiac Death – A Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Paper | Position Statement | |
Heart Failure | 2011 | Heart Failure Guidelines 2011 Update: Focus on Sleep Apnea, Renal Dysfunction, Mechanical Circulatory Support, and Palliative Care | Guideline | |
Prevention / Risk | 2011 | Smoking Cessation and the Cardiovascular Specialist | Position Statement | |
Rehabilitation | 2011 | Systematizing Inpatient Referral to Cardiac Rehabilitation 2010 – A Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society Joint Position Paper | Position Statement | |
Syncope | 2011 | Standardized Approaches to the Investigation of Syncope | Position Statement | |
Adult Echocardiography | 2010 | Echocardiography Guidelines for Training and Maintenance of Competency in Adult Echocardiography | Training and MOC | |
Adult Echocardiography | 2010 | Echocardiography Guidelines for Training and Maintenance of Competency in Adult Echocardiography | Guideline | |
Antiplatelet Therapy | 2010 | Antiplatelet Therapy Guidelines 2010: The Use of Antiplatelet Therapy in the Outpatient Setting | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #5: Catheter Ablation for Atrial Fibrillation/Atrial Flutter | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #2: Etiology and Initial Investigations | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #1: Implementing GRADE and Achieving Consensus | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #3: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #8: Prevention and Treatment of Atrial Fibrillation Following Cardiac Surgery | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #7: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #4: Rate and Rhythm Management | Guideline | |
Atrial Fibrillation | 2010 | Atrial Fibrillation Guidelines 2010 Update #6: Surgical Therapy | Guideline | |
Cardiac Computed Tomography | 2010 | Consensus Training Standards for Cardiac Computed Tomography | Training and MOC | |
Cardiac Electrophysiology | 2010 | Training Standards and Maintenance of Competency in Adult Clinical Cardiac Electrophysiology | Training and MOC | |
Cardiac Electrophysiology | 2010 | Training Standards and Maintenance of Competency in Adult Clinical Cardiac Electrophysiology | Guideline | |
Heart Failure | 2010 | Heart Failure Guidelines 2010 Update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs | Guideline | |
Interventional Cardiology | 2010 | Guidelines for Training and Maintenance of Competency in Adult Interventional Cardiology | Training and MOC | |
Angina | 2009 | Refractory angina pectoris | Position Statement | |
Antiplatelet Therapy | 2009 | Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery | Position Statement | |
CAD/ACS | 2009 | Management of ST elevation myocardial infarction: American College of Cardiology and American Heart Association 2004 Guidelines | Canadian Perspective | |
Dyslipidemia | 2009 | Dyslipidemia Guidelines 2009 Update: Diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult | Guideline | |
Heart Disease | 2009 | Adult Congenital Heart Disease Guidelines Update 2009: Management of Adults with Congenital Heart Disease | Consensus Conference | |
Heart Failure | 2009 | Heart Failure Guidelines 2009 Update: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials | Consensus Conference | |
Imaging / Echo | 2009 | Cardiac computed tomography in 2009, ‘What, when, where, who and how?’, Guidelines for the clinician | Commentary | |
Paediatric Cardiology | 2009 | Cardiac risk assessment before the use of stimulant medications in children and youth – A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry | Position Statement | |
Transplantation | 2009 | Cardiac Transplantation | Consensus Conference | |
Cardiovascular/Heart Disease | 2008 | Endocarditis prophylaxis guidelines: A compromise between science and common sense:American Heart Association 2007 Guidelines | Commentary | |
Heart Failure | 2008 | Heart Failure Guidelines 2008 Update: Best practices for transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies | Consensus Conference | |
Imaging / Echo | 2008 | Contrast Echocardiography: Putting things into perspective – A Canadian Cardiovascular Society/Canadian Society of Echocardiography joint commentary | Canadian Perspective | |
CAD/ACS | 2007 | Drug-eluting stents – A Canadian Association of Interventional Cardiology and Canadian Cardiovascular Society joint statement | Position Statement | |
Heart Failure | 2007 | Heart Failure Guidelines 2007 Update: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers | Consensus Conference | |
Imaging / Echo | 2007 | Contrast Echocardiography in Canada – A Canadian Cardiovascular Society/Canadian Society of Echocardiography Position Paper | Commentary | |
Dyslipidemia | 2006 | Diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease | Position Statement | |
Heart Failure | 2006 | Heart Failure Guidelines 2006: Diagnosis and management | Consensus Conference | |
Imaging / Echo | 2006 | Advanced Non-invasive Cardiac Imaging using Positron Emission Tomography, Magnetic Resonance Imaging and Multi-Detector Computed Tomographic Angiography in the Diagnosis and Evaluation of Ischemic Heart Disease – A joint position statement by CCS / CAR / CANM / CNCS / Can SCMR | Position Statement | |
Device Therapy | 2005 | Implantable Cardioverter Defibrillator Use in Canada – A Canadian Cardiovascular Society and Canadian Heart Rhythm Society position paper | Position Statement | |
Peripheral Arterial Disease | 2005 | Peripheral Arterial Disease | Consensus Conference | |
Prevention / Risk | 2005 | Pulmonary Arterial Hypertension – A Canadian Cardiovascular Society and Canadian Thoracic Society position statement | Position Statement | |
Atrial Fibrillation | 2004 | Atrial Fibrillation Guidelines 2004 | Consensus Conference | |
CAD/ACS | 2004 | STEMI: ACC/AHA Guidelines | Canadian Perspective | |
Cardiovascular/Heart Disease | 2004 | Surgical Management of Valvular Heart Disease | Consensus Conference | |
Imaging / Echo | 2004 | Provision of Echocardiography in Canada | Standards of Practice | |
Transplantation | 2004 | Paediatric and Adult Congential Heart Transplantation | Consensus Conference | |
Assessment to Drive/Fly | 2003 | Fitness to Drive and Fly Guidelines 2003: Assessment of the cardiac patient for fitness to drive and fly (Executive Summary) | Consensus Conference | |
Heart Failure | 2003 | Heart Failure Guidelines 2002/2003: Diagnosis and Management of Heart Failure | Consensus Conference | |
Cardiovascular/Heart Disease | 2002 | Management of Heart Disease in the Elderly Patient | Consensus Conference | |
Prevention / Risk | 2002 | Hormone Replacement Therapy and Cardiovascular Disease – Heart and Stroke Foundation of Canada, Society of Obstetricians and Gynecologists of Canada, Canadian Cardiovascular Society | Position Statement | |
Heart Disease | 2001 | Adult Congenital Heart Disease Guidelines 2001: Management of Adults with Congenital Heart Disease | Consensus Conference | |
Transplantation | 2001 | Cardiac Transplantation | Consensus Conference | |
Cardiovascular/Heart Disease | 2000 | Women and ischemic heart disease | Consensus Conference | |
Prevention / Risk | 2000 | Homocyst(e)ine and Cardiovascular Disease – Heart and Stroke Foundation of Canada | Commentary | |
Arrhythmia | 1999 | Prevention of sudden death from ventricular arrhythmia (Executive Summary) | Consenus Conference | |
Cardiovascular/Heart Disease | 1999 | Sildenafil in the Management of Sexual Dysfunction in Patients with Cardiovascular Disease | Position Statement | |
Prevention / Risk | 1998 | Prevention of cardiovascular diseases: the role of the cardiovascular specialist | Consensus Conference | |
Cardiovascular/Heart Disease | 1997 | Evaluation and Management of Chronic Ischemic Heart Disease | Consensus Conference | |
Cardiovascular/Heart Disease | 1995 | Indications For and Access To Revascularization | Consensus Conference | |
Cardiovascular/Heart Disease | 1992 | Coronary Thrombolysis | Consensus Conference | |
Angina | 1976 | Angina pectoris, a CCS Grading Scale | Consensus Conference | |